Particles for Humanity Welcomes New Finance Leader
Particles for Humanity has appointed Marcus Chapman as Senior Vice President and Head of Finance. This key position will see Chapman take charge of the financial strategy, planning, and operations of the organization as it readies for the commercial launch of PFH-VAP, a groundbreaking formulation of vitamin A aimed for large-scale food fortification.
Marcus Chapman's Extensive Experience
Chapman brings a wealth of experience, accumulating over two decades in operational, strategic, and financial roles within both early-stage and commercial-stage companies. His previous role as Senior Vice President at Flagship Pioneering allowed him to work closely with a variety of early-stage companies, guiding them through early rounds of venture capital funding. His biopharmaceutical background is impressive and includes positions as Principal Financial Officer at Seres Therapeutics and Head of Finance for the Oncology Business Unit at Takeda Pharmaceuticals. In his earlier career, he specialized in life sciences while serving as an Engagement Manager at Strategic Decisions Group and Clarion Healthcare, combining analytical prowess with management skills.
Looking Ahead: The Launch of PFH-VAP
As Particles for Humanity gears up for the expected launch of PFH-VAP in 2026, Chapman's expertise is set to be invaluable. The product aims to tackle vitamin A deficiency, a significant public health concern that affects millions across the globe. With his deep strategic knowledge, Chapman is well-positioned to steer the company through this critical transition from development to commercialization, fostering sustainable growth and significant impact.
The Mission of Particles for Humanity
Particles for Humanity strives to convert innovative early-stage medical technologies into real-world applications for individuals living in low to lower-middle income countries. Their product development methodology is rigorous, highly focused on input from end-users, with a strong emphasis on creating financially sustainable product opportunities. Notably, all funding for the organization comes via philanthropic sources, highlighting their commitment to social impact.
Contact Information
For more information, you can explore their website or reach out directly for inquiries.
Frequently Asked Questions
Who is Marcus Chapman?
Marcus Chapman is the newly appointed Senior Vice President and Head of Finance at Particles for Humanity, bringing two decades of experience in finance and operations.
What is PFH-VAP?
PFH-VAP is a stable formulation of vitamin A aimed at large-scale food fortification, launching commercially in 2026.
What role will Chapman play in the company?
Chapman will oversee financial strategy, planning, and operations as Particles for Humanity prepares for their product launch.
How does Particles for Humanity support public health?
By focusing on vitamin A deficiency, Particles for Humanity aims to address a critical public health challenge affecting millions worldwide.
What is the funding model of Particles for Humanity?
Particles for Humanity is solely funded through philanthropy, ensuring that their mission remains focused on social impact without commercial pressures.
